Printer Friendly

Boehringer Ingelheim obtains United States patent.

University of Michigan (Ann Arbor, MI) has patented methods for the ex vivo formation of mammalian bone and subsequent uses of the bone. A critical and distinguishing feature of the present invention are defined tissue culture conditions and factors resulting in the formation of bone cell spheroids. The invention also provides for methods of implanting into subjects the ex vivo formed bone. Also described are methods for genetically altering the bone cell spheroids to affect bone formation, identification of candidate modulators of bone formation, and identification of genes involved in bone formation. (US 6,811,776)
COPYRIGHT 2004 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Comment:[0] Boehringer Ingelheim obtains United States patent.
Publication:BIOTECH Patent News
Article Type:Brief Article
Geographic Code:1USA
Date:Oct 1, 2004
Words:96
Previous Article:Boehringer Ingelheim obtains United States patent.
Next Article:Boehringer Ingelheim obtains United States patent.
Topics:


Related Articles
Valentis and Boehringer Ingelheim to collaborate on gene medicine for rheumatoid arthritis.
BOEHRINGER STANDARDIZES ON SIEBEL EBUSINESS APPLICATIONS.
MorphoSys widens scope of United States patent for HuCAL technology.
Jury renders decision in Schering-Plough animal vaccine infringement suit.
MorphoSys and Boehringer Ingelheim start new antibody program.
Boehringer Ingelheim obtains United States patent.
Boehringer Ingelheim obtains United States patent.
Boehringer Ingelheim obtains United States patent.
Boehringer Ingelheim obtains United States patent.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters